Atallah Joseph, Collins Kathryn K, Jonas Richard A, Mayer John E, Triedman John K
Departments of Cardiology and Cardiovascular Surgery, Children's Hospital Boston, Harvard Medical School, Boston, MA, USA.
Congenit Heart Dis. 2012 May-Jun;7(3):219-25. doi: 10.1111/j.1747-0803.2012.00636.x. Epub 2012 Feb 16.
Atrial arrhythmias represent significant morbidity and risk for mortality in Fontan patients. In a randomized trial involving patients undergoing a lateral tunnel Fontan between 1999 and 2001, Collins et al. investigated the safety and efficacy of a surgical atrial incision aimed at decreasing the incidence of intraatrial reentrant tachycardia (IART). The purpose of this study was to report the late follow-up of the aforementioned trial.
All surviving patients previously enrolled in the randomized trial were eligible for this follow-up study. Patients' legal guardians were contacted for informed consent and data were obtained form a retrospective chart review.
Of the 39 eligible patients, 29 were recruited: 15 in the intervention and 14 in the control groups. The median follow was 9.0 (1.2) years for the intervention group and 9.3 (1.1) years for the control group (P= .86). At most recent follow-up, there was no statistically significant difference in the demographic, echocardiographic, and electrophysiological data between the two groups. There was no late incidence of the primary outcome, IART. There were nine cases of late-onset sinus node dysfunction (SND): 5/15 in the intervention and 4/14 in the control groups (P= .99). There was only one late pacemaker implantation for early post-op SND.
At late follow-up 9 years post-Fontan, IART had not occurred in either group. There was no evidence of late-onset complications related to the interventional atrial incision. Further follow-up is warranted for this cohort.
房性心律失常在Fontan手术患者中代表着显著的发病率和死亡风险。在一项1999年至2001年间纳入接受侧隧道Fontan手术患者的随机试验中,柯林斯等人研究了旨在降低房内折返性心动过速(IART)发生率的外科心房切口的安全性和有效性。本研究的目的是报告上述试验的晚期随访情况。
所有先前纳入随机试验的存活患者均符合本随访研究的条件。联系患者的法定监护人以获取知情同意,并通过回顾性病历审查获取数据。
在39名符合条件的患者中,招募了29名:干预组15名,对照组14名。干预组的中位随访时间为9.0(1.2)年,对照组为9.3(1.1)年(P = 0.86)。在最近一次随访时,两组在人口统计学、超声心动图和电生理数据方面无统计学显著差异。主要结局IART无晚期发生率。有9例迟发性窦房结功能障碍(SND):干预组5/15,对照组4/14(P = 0.99)。仅因术后早期SND有1例晚期起搏器植入。
在Fontan手术后9年的晚期随访中,两组均未发生IART。没有证据表明与介入性心房切口相关的迟发性并发症。该队列有必要进行进一步随访。